EIKONIZO THERAPEUTICS
Eikonizo Therapeutics, Inc. was founded in October 2017 based on discoveries from Dr. Jacob Hooker’s academic lab (at MGH (Massachusetts General Hospital) and the Martinos Center for Biomedical Imaging) around novel small molecule design and human PET neuroimaging agents. ‘Eikonizo’ (ee-kuh-NEE-zo) is Greek for ‘envision’ or ‘imagine’. It captures their strategy to use PET imaging early in the drug discovery process to de-risk novel targets and lead therapeutic candidates, allowing... us to envision an accelerated path to drug discovery and development. This is especially needed for brain diseases, where drug development is typically hampered by the inability to measure whether a drug has even gotten to the brain. They’re applying this approach in their lead project focusing on novel small molecule therapeutics for neurodegenerative diseases, such as Alzheimer’s Disease and ALS.
EIKONIZO THERAPEUTICS
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2017-01-01
Address:
Beverly, Massachusetts, United States
Country:
United States
Website Url:
http://www.eikonizo.com
Total Employee:
1+
Status:
Active
Contact:
(617) 308-4405
Total Funding:
2 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Apple Mobile Web Clips Icon WordPress Content Delivery Network Font Awesome Wordpress Plugins
Similar Organizations
7i Group
7i Group is a health care partner.
Addicere Therapeutics
Addicere Therapeutics is a Health Care company.
Arkuda Therapeutics
Arkuda Therapeutics is a pharmaceutical company.
Curon Biopharma
Curon Biopharma is a Healthcare company.
Emendo Biotherapeutics
Emendo Biotherapeutics is a biotechnology company
Eximias Pharmaceutical Corporation
Eximias Pharmaceutical Corporation is a Health Care company.
Hangzhou Just Biotherapeutics (Just China)
Hangzhou Just Biotherapeutics is a comprehensive high-tech design company.
ImmunOs Therapeutics
ImmunOs Therapeutics is a clinical-stage biotechnology company.
Mahzi Therapeutics
Mahzi Therapeutics is a health care and biotechnology company.
Nymox Pharmaceutical
Nymox Pharmaceutical is a biopharmaceutical company.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Stochos Therapeutics
Stochos Therapeutics is a healthcare company.
Current Employees Featured
Founder
Official Site Inspections
http://www.eikonizo.com Semrush global rank: 4.85 M Semrush visits lastest month: 1.83 K
- Host name: 11.0.153.160.host.secureserver.net
- IP address: 160.153.0.11
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Eikonizo Therapeutics"
Eikonizo – Eikonizo is developing life-changing …
Eikonizo is developing disease-modifying therapies by creating brain penetrant and peripheral small molecules to improve the lives of people impacted by neurodegenerative, cardiorenal and other diseases. Our Programs Eikonizo is …See details»
About Us - Eikonizo
About Eikonizo . We are committed to developing life-changing therapies. Eikonizo (ee-kƏ-NEE’-zo) verb [Greek] to envision, visualize, or imagine. Eikonizo’s vision is to develop novel, …See details»
Eikonizo Therapeutics - Crunchbase Company Profile
Eikonizo Therapeutics, Inc. was founded in October 2017 based on discoveries from Dr. Jacob Hooker’s academic lab (at MGH (Massachusetts General Hospital) and the Martinos Center for Biomedical Imaging) around novel small …See details»
Eikonizo Therapeutics - LinkedIn
Eikonizo is developing life-changing therapies by creating brain-penetrant small molecules and deploying in vivo target engagement techniques to accelerate the identification of therapeutics.See details»
Eikonizo Therapeutics Company Profile 2024: …
Eikonizo Therapeutics General Information Description. Developer of small molecule therapeutic drugs designed to treat neurodegenerative disease. The company employs various gene therapy techniques, including viral vectors, to …See details»
Our Science - Eikonizo
Eikonizo is also developing similarly differentiated peripheral HDAC6 inhibitors for cardiorenal and other indications, such as ADPKD, Diabetic Nephropathy and heart failure. Our lead CNS …See details»
Eikonizo Therapeutics - VentureRadar
Eikonizo is developing life-changing therapies by creating brain-penetrant small molecules and deploying in vivo target engagement techniques to accelerate the identification of therapeutics. …See details»
Eikonizo Therapeutics - Contacts, Employees, Board Members
Organization. Eikonizo Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies ... including Co-Founder and Director …See details»
Eikon Therapeutics
Nov 20, 2024 We seek to advance breakthrough therapeutics through the purposeful integration of engineering and science.See details»
Eikonizo Therapeutics, Inc. | Alzheimer's Drug Discovery Foundation
Our company, Eikonizo (Greek for 'envision' or 'imagine'), brings together expertise in epigenetics, small molecule design and in vivo neuroimaging. Through this proposal, our goal is to evaluate …See details»
Dementia-Treatment Startup Seeks to Overcome Prior Drugs’ …
Sep 24, 2019 Eikonizo, which has operated quietly until now, is in the process of raising up to $12 million in Series A funding to move its therapeutic drug toward initial clinical trials, co …See details»
The McQuade Center for Strategic Research and Development and …
PRINCETON, N.J. – (February 9, 2021) – The McQuade Center for Strategic Research and Development, LLC (MSRD), a member of the global Otsuka family of pharmaceutical …See details»
Eikonizo Therapeutics Announces Publication of the ... - Business …
Jul 8, 2020 Eikonizo is a biotechnology company committed to creating life-changing therapies by discovering brain-penetrant small molecules to slow or stop neurodegeneration and …See details»
The McQuade Center for Strategic Research and Development and …
Feb 9, 2021 Eikonizo Janice Kranz Eikonizo Therapeutics, Inc. [email protected] +1 617 302 6817 Contacts Otsuka In the U.S. Robert Murphy Corporate Communications Otsuka America …See details»
Our Team - Eikonizo
Professor, MGH, Harvard, Martinos Center for Biomedical Imaging. Developed first-in-class HDAC neuroimaging tools >130 manuscripts, 8 patents, 2 INDs, 7 IND CMC packagesSee details»
Eikonizo Therapeutics - Craft
Eikonizo is a company that develops therapies for neurological disorders deploying in vivo target engagement techniques. It creates brain-penetrant, small molecule, selective histone …See details»
EKZ-001 by Eikonizo Therapeutics for Alzheimer's Disease: …
Aug 28, 2024 Eikonizo Therapeutics is a biotechnology company that develops life-changing therapies by creating brain-penetrant and peripherally restricted small molecules. The …See details»
Otsuka, Eikonizo Collaborating on ALS, Rare Disease Therapies
Feb 18, 2021 “We are dedicated to seeking out and supporting novel treatments for complex and rare diseases,” Robert McQuade, PhD, president of MSRD and chief strategic officer at …See details»
Our Publications - Eikonizo
Women of the C-Suite: “Your career path might not always be linear,” With Janice Kranz, Ph.D. of Eikonizo Therapeutics. Read article. March 4, 2020. Nearly $4 Million In Research Funding …See details»
Therapeutic Hypothesis - Eikonizo
Increases acetylation of α-tubulin which strengthens the mechanical resilience of microtubules, improving transport of cargos along the microtubule. Increases acetylation of Miro1 which …See details»